UK markets closed

C4 Therapeutics, Inc. (CCCC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.18-0.14 (-2.22%)
As of 11:32AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7798
Avg. Estimate-0.35-0.5-1.85-1.92
Low estimate-0.6-0.73-2.52-3.01
High estimate-0.18-0.28-1.08-0.81
Year ago EPS-0.71-0.73-2.65-1.85
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5666
Avg. Estimate8.1M3.88M26.83M21.45M
Low estimateN/AN/AN/AN/A
High estimate12.5M8.5M46M50M
Year ago sales5.15M2.66M20.76M26.83M
Sales growth (year/est)57.30%45.60%29.30%-20.10%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.75-0.69-0.66-0.68
Actual EPS-0.71-0.73-0.55-0.7
Difference0.04-0.040.11-0.02
Surprise %5.30%-5.80%16.70%-2.90%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.35-0.5-1.85-1.92
7 days ago-0.35-0.5-1.85-1.92
30 days ago-0.35-0.5-1.85-1.92
60 days ago-0.35-0.5-1.85-1.92
90 days ago-0.53-0.56-2.36-2.76
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCCCCIndustrySector(s)S&P 500
Current qtr.50.70%N/AN/AN/A
Next qtr.31.50%N/AN/AN/A
Current year30.20%N/AN/AN/A
Next year-3.80%N/AN/AN/A
Next 5 years (per annum)22.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A